213
Participants
Start Date
April 30, 2012
Primary Completion Date
October 31, 2015
Study Completion Date
October 31, 2015
Pertuzumab
Loading dose of 840 mg on Day 1 of first 21-day cycle, followed by 420 mg on Day 1 of each subsequent cycle.
Trastuzumab
Loading dose of 8 mg/kg on Day 1 of first 21-day cycle, followed by 6 mg/kg on Day 1 or 2 of each subsequent cycle.
Vinorelbine
A dose of 25 mg/m\^2 followed by 30-35 mg/m\^2 on Days 2 and 9 of the first 21-day cycle and on Days 1 and 8 (or Days 2 and 9) of each subsequent cycle.
København Ø
Herlev
Odense
Herning
Caen
Genoa
Hamburg
Monza
Plérin
Barbastro
Fredericksburg
Périgueux
Cremona
Leer
Durham
Madrid
Málaga
Marietta
Oviedo
Hollywood
Aviano
Miami
Plantation
Gütersloh
Kassel
Negrar
Tours
San Cristóbal de La Laguna
Goslar
La Tronche
Santander
Mont-de-Marsan
Bologna
Columbus
Dortmund
Valencia
Moers
Georgsmarienhütte
Cologne
Würselen
Lido di Camaiore
Pisa
Frankfurt am Main
Lebach
Strasbourg
Kaiserslautern
Heidelberg
Pierre-Bénite
Paris
Paris
Rouen
Houston
San Antonio
Freiburg im Breisgau
Denver
München
München
Avignon
Ogden
Tucson
Ravensburg
Neumarkt
Bobigny
Villejuif
Seattle
Seattle
Stanford
Boston
Morristown
Rio de Janeiro
Barretos
São Paulo
São Paulo
São Paulo
Dresden
Rome
Terni
Badajoz
Palma de Mallorca
Terrassa
Hoffmann-La Roche
INDUSTRY